ArticlePulmonary circulation

TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension.

Robert P Frantz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.